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Abstract 
In cancer, both histopathological images and genomic signatures are used for diagnosis, 
prognosis, and subtyping. However, combining histopathological images with genomic data for 
predicting prognosis, as well as the relationships between them, has rarely been explored. In this 
study, we present an integrative genomics framework for constructing a prognostic model for clear 
cell renal cell carcinoma. We used patient data from The Cancer Genome Atlas (n = 410), 
extracting hundreds of cellular morphological features from digitized whole-slide images and 
eigengenes from functional genomics data to predict patient outcome. The risk index generated by 
our model correlated strongly with survival outperforming predictions based on considering 
morphological features or eigengenes separately. The predicted risk index also effectively 
stratified patients in early-stage (stage I and stage II) tumors, whereas no significant survival 
difference was observed using staging alone. The prognostic value of our model was independent 
of other known clinical and molecular prognostic factors for patients with clear cell renal cell 
carcinoma. Overall, this workflow and the shared software code provide building blocks for 
applying similar approaches in other cancers.  
Introduction 
Histopathological images confer important information for diagnosis, staging, and prognosis 
for cancers and are being used extensively by pathologists in clinical practice. With the recent 
availability of digital whole-slide images (1), automated computational histopathological image 
analysis systems have shown great promise in diagnosis and the discovery of new biomarkers for 
cancers such as breast (2–4), lung (5,6), brain (7), and colon cancers (8). In comparison with human 
inspection, computerized image analysis has great potential to improve efficiency, accuracy, and 
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consistency. Besides histopathological images, molecular characteristics, such as genetic 
alterations and gene expression signatures, are also widely adopted for predicting clinical 
outcomes for cancers (9,10). Therefore, an interesting scientific question is the relationship 
between morphological and genomic features while an important translational question is if the 
integration of these two types of features can lead to more accurate prediction of patient outcome. 
This has been previously explored in various cancers including breast, ovarian, and glioblastoma,  
and led to new insights into the relationship between cancer tissue morphology and genetic 
changes such as PTEN mutations (3,11–13).  
To study these issues, matched histopathological images and genomic datasets for cancers are 
needed. Fortunately, The Cancer Genome Atlas (TCGA) project not only provides an extensive 
collection of genomics and clinical outcome data for large cohorts of patients of more than 30 
types of cancers, but also hosts a large collection of matched histopathological images for solid 
tumor samples. Currently, more than 24,000 histopathological images are available at the TCGA 
data portal and can be visualized at the Cancer Digital Slide Archive (CDSA, 
http://cancer.digitalslidearchive.net/) (14).  
Quantitative analysis of these images and integration with genomics data require innovation in 
integrative genomics and call for techniques from bioimage informatics, genomics, and 
bioinformatics. We previously developed a computational framework for quantifying 
morphological features from large histopathological images (4,15) as well as genomics 
visualization tools for integrating imaging, clinical, and genomic features to predict patient 
outcomes (4,16,17). Therefore, to further promote this emerging integrative genomics field 
straddling bioimage informatics and genomics and ensure wide utilization of valuable large 
datasets, we demonstrate an integrative genomics workflow on the less well-studied renal cancers. 
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The analysis tools are publicly available and can be adopted as building blocks for other integrative 
genomics workflows (please see Methods section).  
Renal cell carcinoma (RCC) is the most common type of malignant neoplasm arising from 
kidney in adults, responsible for approximately 90-95% of all cases (18). It can be categorized into 
the following histologic subtypes: clear cell, papillary, chromophobe, collecting duct, and 
unclassified RCC based on the Heidelberg classification system (19).  In this study, we focus on  
clear cell renal cell carcinoma (ccRCC), which is the most prevalent subtype, accounting for 80-
90% of all RCCs (20).  In clinical practice, tissue sections are examined under a microscope by 
pathologists to make a diagnosis and predict prognosis. The clinical behavior of ccRCC is quite 
diverse,  ranging from slow-growing localized tumors to aggressive metastatic disease (9). 
Therefore, prognostic markers play a crucial role in stratification of patients for personalized 
cancer management, which could avoid either over-treatment or under-treatment (21). For instance, 
patients classified into high-risk group may benefit from closer follow-up, more aggressive 
therapies, and advance care planning (5,22). Currently, prognostic markers for ccRCC in routine 
clinical use consist mainly of tumor stage, nuclear grade, and presence of necrosis (23–25). 
However, cancer is a highly heterogeneous disease. The prediction accuracy of traditional clinical 
factors remains limited for individual patients, especially for early-stage patients, and also relies 
on the experience of pathologists. Therefore, there is a need for more effective markers for 
predicting prognosis of ccRCC. 
Using the large cohort of ccRCC patients from TCGA, hundreds of cellular morphological 
features can be extracted from hematoxylin and eosin (H&E) stained whole-slide images, 
characterizing nucleus size, shape, texture, and the spatial relationship between nuclei. In this 
paper, we demonstrate how image features correlate with co-expressed gene signatures and 
6 
 
developed an automated prognostic model that could predict patient’s survival risk for patient 
stratification, using a combination of quantitative image features and eigengenes. To the best of 
our knowledge, this is the first study to couple histopathological images and genomic data to 
predict ccRCC clinical outcome and our results indicate that the integration of imaging and 
genomic features can lead to improved prognosis prediction for early-stage (stages I and II) ccRCC 
patients than existing clinical markers.  
Materials and methods 
Data and codes availability 
Processed data (extracted quantitative imaging features, combined gene expression data, etc.) 
and code with annotations, comments and instructions are available at 
https://github.com/chengjun583/image-mRNA-prognostic-model.  
Data source and selection 
ccRCC patient samples used in our study included matched H&E stained whole-slide images, 
transcriptome, somatic mutation, and clinical information, which were acquired from TCGA data 
portal at NCI Genomic Data Commons (26). Patients with missing or too short (i.e., less than 30 
days) follow-up were excluded. Microscopic images (20X and 40X magnification) were obtained 
from TCGA. The demographic and clinical characteristics for the selected 410 patients are 
summarized in Table 1.  
One challenge for this study was the lack of other large cohorts of ccRCC with matched 
histological image and genomic data. Thus, instead of using a second dataset for validation, we 
applied cross-validation in every step of downstream of the machine learning analysis as described 
below.  
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Data analysis and integration workflow 
Fig. 1 outlines our data analysis workflow for both imaging and genomic data for both 
univariate and multivariate analyses with details of each major step being described in the 
following sections. 
Histopathological image features 
Our image feature extraction pipeline consists of three steps: nucleus segmentation, cell-level 
feature extraction, and aggregation of cell-level features into patient-level features (Fig. 1A). Rich 
pathological information is present in stained cell nuclei that requires segmentation to facilitate 
subsequent analyses. For this task, a recently proposed approach by Phoulady et al (27) was 
employed, which is an unsupervised segmentation method requiring no parameter learning or 
training data because the parameters are set adaptively. Next, ten types of cell-level features were 
extracted for each segmented nucleus, characterizing nucleus size, shape, texture, and distance to 
neighbors. These cell-level features are nuclear area (denoted as area), lengths of the major and 
minor axes of cell nucleus and the ratio of major axis length to minor axis length (major, minor, 
and ratio), mean pixel values of nucleus in RGB three channels respectively (rMean, gMean, and 
bMean), and mean, maximum, and minimum distances (distMean, distMax, and distMin) to 
neighboring nuclei in the Delaunay triangulation graph (28). The Delaunay triangulation graph 
was constructed based on the locations of segmented nuclei. In this graph, each nucleus was a node 
and connected to neighboring nuclei. Finally, for each type of cell-level features, a ten-bin 
histogram and five distribution statistics (i.e. mean, standard deviation, skewness, kurtosis, and 
entropy) were adopted to aggregate the numerous cell-level features extracted from a patient into 
patient-level features; 150 patient-level features were generated in total. Taking the cell-level 
feature, area, as an example, corresponding 15 patient-level features were denoted as area_bin1 to 
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area_bin10 for the 10 histogram features, and area_mean, area_std, area_skewness, area_kurtosis, 
and area_entropy for the 5 distribution statistics. For other cell-level features, corresponding 
patient-level features were named in the same way. Area_bin1 represents the percentage of very 
small nuclei over the entire slide for a patient while area_bin10 indicates the percentage of very 
large nuclei in the patient sample. Skewness is a measure of the asymmetry of the data distribution 
around the sample mean, kurtosis is a measure of how outlier-prone a distribution is, and entropy 
is a statistical measure of randomness.  
Additional description about aggregation of cell-level features into patient-level features is 
provided in the Supplemental Material. A qualitative example of nucleus segmentation results is 
shown in Fig. S1. 
Gene co-expression analysis and summarization 
mRNA expression profiles for the ccRCC tumors in TCGA were transformed from Illumina 
HiSeq 2000 RNA-seq readcounts to normalized RPKM (reads per kilobase per million). While our 
first goal was to establish the relationships between gene expression data and the imaging features, 
the large number of genes posed a challenge to obtaining sufficient statistical power. Therefore 
instead of focusing on individual genes, we first carried out gene co-expression network analysis 
(GCNA) to cluster genes into co-expressed modules and summarized each module as an 
“eigengene” using the protocol described in (29) (Fig. 1B). Modules are clusters of highly 
interconnected/correlated genes. The eigengene of a module is defined as the first principle 
component, which can be considered a representative of the gene expression profiles in a module. 
This approach not only substantially improves statistical power (30), but also allows us to focus 
on important biological processes or genetic variations associated with the co-expressed gene 
modules, making the results more interpretable than individual genes as the co-expressed modules 
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are often strongly associated with a specific gene group participating in the same biological process 
or located on the same chromosomal band. 
While there are many algorithms for performing GCNA including the well-known WGCNA 
package (31), we applied our recently developed weighted network mining algorithm called local 
maximum quasi-clique merging (lmQCM) (32). Unlike WGCNA, which uses hierarchical 
clustering and does not allow overlap between modules, our algorithm is a greedy approach 
allowing genes to be shared among multiple modules, consistent with the fact the genes often 
participate in multiple biological processes. In addition, we have shown that lmQCM can find 
smaller co-expressed gene modules that are often associated with structural mutations such as copy 
number variation in cancers (32). The lmQCM algorithm has four parameters γ, α, t, and β. 
Among these parameters, γ is the most influential, as it determines if a new module can be 
initiated by setting the weight threshold for the first edge of the module as a subnetwork. In the 
lmQCM algorithm, we transformed the absolute values of the Spearman correlation coefficients 
between expression profiles of genes into weights using a normalization procedure adopted from 
spectral clustering for which we have shown to be effective in previous studies (33). In practice, 
we found with γ = 0.30, t = 1, α = 1, and β = 0.4 the algorithm yielded 15 co-expressed gene 
modules (Table S1) with balanced sizes and clear biological interpretation based on enrichment 
analysis (Table S2). 
Machine-learning methods for prognosis prediction 
We built a lasso-regularized Cox proportional hazards (lasso-Cox) model (R package “glmnet”) 
to calculate the risk index of each patient (34), based on the cellular morphological features and 
eigengenes (Fig. 1C). Lasso penalty (i.e. L1 penalty) can induce sparsity and thus select an 
informative subset of features. To validate our method, we used a two-level cross validation (CV) 
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strategy. After each patient was used as a test sample and classified into a low-risk or high-risk 
group, we used Kaplan-Meier estimator and log-rank test to test if these two groups had distinct 
survival.  
Additional description of the training and prediction process is provided in Supplemental 
Material. 
Statistical methods and enrichment analysis 
To screen survival-associated features, for each patient-level feature we divided patients into 
two groups (low and high groups) where the median of each feature was used as a cut-off point. 
Kaplan-Meier estimator was used for patient stratification, and p value was calculated with the 
log-rank test, where p < 0.05 was considered significant. For the initial survival analysis, since our 
initial goal was screening, we did not apply multiple test compensation such as FDR control in 
order to obtain more candidate features. The lasso-Cox model was learned on the selected survival-
associated features. Cox proportional hazards regression model was fitted, and 95% confidence 
intervals were computed to determine the prognostic values of our lasso-Cox risk indices and other 
known prognostic factors. Correlation was computed using Spearman rank correlation coefficients. 
Enrichment analysis of co-expressed gene modules was carried out using Toppgene (35). All the 
survival analyses were performed using R package “survival.” 
Results 
Both image and gene expression data identify poor-prognosis subtype with high percentage 
of tumor stroma 
To investigate which specific image features and eigengenes are associated with patient survival, 
we tested for each feature the statistical significance of difference in overall survival between low 
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and high risk groups that were stratified by the median of feature values. Log-rank test results 
revealed that 33 image features and 6 eigengenes were significantly related to prognosis (p < 0.05). 
The log-rank test results of all survival-related variables are listed in Table 2 and the Kaplan-Meier 
survival curves for some variables are shown in Fig. 2A-E. 
After examining these survival-associated variables, we found many of them were connected 
to stroma tissue. Stromal cells such as fibroblasts are typically spindle-shaped with elongated 
nuclei and therefore characterized by long major axes and/or large ratio between major and minor 
axes. As shown in Table 2, Fig. 2A and B, image features such as major_bin8, major_bin9, 
ratio_bin8, ratio_bin9, ratio_std, and major_std, were negatively related to prognosis, that is, 
patients with large values of these variables had worse prognosis than other patients. Large values 
of these variables imply a high percentage of stromal cell nuclei in whole-slide images (in terms 
of major_std, and ratio_std, large values of these variables mean that the major axis length and the 
ratio of major axis length to minor axis length are spread out in a wide range, indicating a high 
percentage of stromal cell nuclei). In other words, patients with high percentage of stromal tissue 
are related to poor prognosis for ccRCC in our study.  
In addition to histopathological images, gene expression data also corroborated that stroma 
played an important role in tumor prognosis. Enrichment analysis showed that gene module 2 was 
enriched with extracellular matrix genes (Table S2), which is consistent with our knowledge that 
the tumor microenvironment plays critical roles in tumor development (2,3). Kaplan-Meier 
survival curves demonstrated distinctly different outcomes for low- and high-expression groups 
(log-rank test p value = 0.024), where high expression of eigengene 2 was associated with poor 
prognosis.  
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Integrative analysis enhances prognostic prediction power 
In the previous sections, we showed that many individual features derived from 
histopathological images and genomic data stratified patients with distinct prognosis. We next 
investigated if the integration of all identified survival-associated features would provide better 
prognostic prediction. We built a lasso-regularized Cox proportional hazards model to select the 
most informative features and calculate a risk index for each patient. Based on the risk indices, 
patients were divided into a low- or high-risk group by the median. The lasso-Cox model provided 
significantly better patient stratification than that using individual features (Fig. 2D-F, log-rank 
test p values = 2.23e-5, 7.46e-6, and 8.79e-10 for the most significant image feature, rMean_bin10, 
the most significant eigengene expression, eigengene3, and lasso-Cox model, respectively). 
Among the 33 survival-associated image features and six survival-associated eigengenes, eight 
image features and five eigengenes were selected: rMean_bin6, major_bin9, area_bin5, 
gMean_bin10, ratio_bin7, ratio_bin8, ratio_bin9, major_bin1, eigengene1, eigengene3, 
eigengene9, eigengene11, and eigengene13 (Enrichment analyses of survival-related gene 
modules are listed in Table S2). Both image features and eigengenes appeared in the final selected 
feature set, and most of the pairwise mutual information values between them are smaller than the 
ones between significantly correlated image features and eigengenes (Fig. S2), suggesting that 
histopathological images and genomic data complement each other in predicting survival outcome. 
Survival-associated image features correlate with eigengenes 
Genotype is one of the three factors that determine phenotype, the other two being inherited 
epigenetic factors and non-inherited environmental factors. Therefore, tumor characteristics or 
morphology is very likely to have some relationships with gene expression data. To find out these 
relationships, we calculated Spearman rank correlation coefficients between each pair of 33 
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survival-associated image features and all eigengenes for the 15 modules. The heat map of the 
correlation matrix is shown in Fig. 3.   
As can be seen from the heat map, eigengenes 2, 3, 9, and 11 significantly correlated with many 
image features (statistically significant after Bonferroni correction). The gene module 2 was 
enriched with extracellular matrix genes, which explained why it positively correlated with image 
features such as ratio_bin8, ratio_bin9, ratio_std, major_bin9, and major_std that describe the 
percentage of stromal cells. Gene module 3 was enriched with acid metabolic process and 
transmembrane transporter activity. Genes in this module play a central role in renal functions 
such as organic anion transport (36). Patients with low expression of this eigengene were related 
to poor prognostic outcome (log-rank test p value = 7.46e-6, Fig. 2E), implying impaired renal 
function. This eigengene also negatively correlated with images features representing the amount 
of stromal cells such as ratio_bin9, major_bin9, ratio_std, and major_std. Gene module 9 was 
highly enriched with cell cycle and mitosis genes. In fact, genes in this module are frequently 
observed to co-express in multiple types of cancers (37). High expression of this eigengene 
indicates that the tumor is more aggressive, and it was negatively related to patient prognosis (log-
rank test p value = 1.19e-4). Cells become bigger when they come into mitotic phase, which was 
in line with our observation that the gene module 9 was significantly and positively correlated with 
image features such as area_bin5, area_bin6, and area_std. The top molecular functions of gene 
module 11 by were frizzled binding and G-protein coupled receptor binding. G-protein-coupled 
receptors (GPCRs) represent the largest family of cell-surface molecules involved in signal 
transduction. Experimental and clinical data indicate that GPCRs have a crucial role in cancer 
progression and metastasis (38). Patients with high expression of gene module 11 had significantly 
worse outcome than other patients (log-rank p value = 1.33e-3). Similar to gene module 2, module 
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11 also significantly correlated with many image features that describe stroma cells, such as 
ratio_bin8, ratio_bin9, and ratio_std. Survival analysis results and enrichment analysis results for 
all survival-associated eigengenes are summarized in Table 2 and Table S2, respectively. 
Lasso-Cox risk index is independent of known prognostic factors 
Using univariate and multivariate Cox proportional hazards analysis, we performed a 
comprehensive comparison between the lasso-Cox risk index and other known prognostic 
biomarkers, including two clinical variables, grade (G1+G2 vs. G3+G4), stage (I+ II vs. III+ IV), 
six gene expression signatures (39,40), CSNK2A1, SPP1, DEFB1, CD31, EDNRB, TSPAN7, and 
five somatic mutation genes (26,41–46), VHL, PBRM1, BAP1, SETD2, TP53. Patient subtyping 
for gene expression signatures was carried out by using the median as cut-off point. In terms of 
genes with somatic mutation, patients were classified as mutant or wild-type. Of these factors, only 
grade, stage, lasso-Cox risk index, DEFB1, EDNRB, and TSPAN7 were associated with survival 
by univariate Cox proportional hazards analysis (Table 3). DEFB1 encodes beta-defensin, which 
belongs to a family of antimicrobial peptides produced by white blood cells and epithelial cells. 
Rabjerg (40) suggested that DEFB1 might be a tumor suppressor gene, but our results revealed 
that high expression of this gene predicted a worse prognosis with very weak significance (p = 
4.99e-2, hazard ratio = 1.41, and 95% confidence interval = [1.00, 1.98]). EDNRB is a member of 
the endothelin axis, and TSPAN7 is a member of the transmembrane 4 superfamily. Wuttig (39) 
showed that EDNRB and TSPAN7 might be suppressors of tumor progression and metastatic 
tumor growth, which is in agreement with our results that high expression of these two genes 
predicted a better prognosis. Subsequently, multivariate Cox proportional hazards analysis 
demonstrated that lasso-Cox risk index was an independent prognostic factor (p = 2.31e-4, hazard 
ratio = 2.26, 95% confidence interval 1.46-3.49), as well as stage and TP53 (Table 3).    
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Predicting survival in early-stage ccRCC 
As shown in Table 3, tumor stage is the most effective prognostic factor, but its capability of 
stratifying early-stage (i.e. stage I and II) ccRCC patients is very limited (Fig. 4A and B). The 
Kaplan-Mejer curves of stages I and II are intertwined (log-rank test p value = 0.962), which may 
be attributed to the less significant morphological differences between stages I and II tumors and/or 
large subtyping variations among pathologists. 
However, the image features and eigengenes can successfully stratify early-stage patients with 
distinct survival outcomes. Log-rank testing of each of the 165 variables (150 image features and 
15 eigengenes) revealed that 13 image features and 2 eigengenes were associated with survival 
(Table S3). Survival curves of 3 variables are shown in Fig. 4C-E. In addition, we also trained a 
lasso-Cox prognostic model using the above 15 variables related to survival. Fig. 4F shows the 
survival curves stratified by the lasso-Cox risk index (log-rank test p value = 0.014). Compared to 
individual variables, integrating image features and eigengenes did not improve the accuracy of 
prognostic prediction for early-stage patients while there indeed was a very significant 
improvement when using all patients. This is because the death rate in early-stage patients is much 
lower than that in all patients (18.5% vs 32.9%), and high death rate is key to ensuring prediction 
accuracy of lasso-Cox model. If all patients were used in the lasso-Cox model to predict early-
stage patient prognosis, the performance was improved (log-rank test p value = 8.65e-3). The two 
eigengenes associated with the prognosis of the early-stage patients corresponded to co-expressed 
gene modules 3 and 13. The gene module 3 was highly enriched with genes related to kidney 
functions such as organic acid metabolic process (𝑝𝑝 = 5.702 × 10−18), ammonium ion metabolic 
process (𝑝𝑝 = 6.612 × 10−9), and anion transport (𝑝𝑝 = 5.994 × 10−8). This observation suggests 
that the physiological functions for kidney can be potential prognostic markers for early-stage 
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patients. Besides gene module 3, gene module 13 contains 10 genes. Interestingly, all the 10 genes 
locate on the same chromosome, straddling chromosome 14q11 to 14q32, implying potential copy 
number variation on 14q may be related to the prognosis of kidney patients. 
Sensitivity analysis 
Since our analysis relies on parameters for the machine learning algorithms and choices of cross 
validation (CV) methods, we also examined the choice of various parameters, especially the choice 
of number of clusters K for the cellular features. Fig. S3 shows the log-rank test p value as a 
function of the number of clusters in K-means algorithm. Fig. S3 suggests that lasso-Cox model 
can achieve very low p values when K ranges from 8 to 14. We also compared leave-one-out CV 
with k-fold CV. Fig. S4 shows that as k increases, the p value tends to continuously decline. This 
is because in k-fold CV a large k means we have more training samples, and thus the learned model 
is likely to perform better especially when the whole data set is not very large. As a result, we 
chose K=10 in the K-means algorithm, and we used leave-one-out CV in our experiments. 
Discussion 
To our knowledge, this is the first study to predict the survival outcomes of ccRCC patients 
using a combination of quantitative morphological features extracted from whole-slide tissue 
images and gene expression signatures. In this study, we developed an automatic image analysis 
pipeline to extract hundreds of cellular morphological features, and found cellular morphology 
was highly linked to co-expressed gene signatures. For example, image features characterizing the 
amount of stromal cells positively correlated with extracellular matrix genes. Standard deviation 
of nuclear area correlated with genes that regulate cell cycle and mitosis.  In addition, a powerful 
prognostic model was built to predict the survival outcomes of ccRCC patients using these two 
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types of data. The performance of the integrated prognostic model significantly outperformed that 
of individual image or genomic features, which indicates that image data are complementary to 
genomic data for predicting patient prognosis. Using multivariate Cox regression, we verified that 
the risk index generated by our model was a prognostic factor independent of tumor grade, stage, 
and other known molecular markers. For early-stage patients, besides the imaging data, the 
genomic data suggests that the kidney functions and status of 14q may be predictors of the survival 
time for these patients. 
Recent studies have underscored the important contribution of stromal gene expression and 
morphologic phenotypes to cancer growth and progression for breast cancer (2,3,47). The 
implication of tumor stroma to prognosis could be different for different cancer types. For instance, 
high percentage of tumor stroma is associated with poor prognosis in triple-negative disease but 
good prognosis in estrogen receptor-positive disease (48,49). Here, we found in this study that for 
ccRCC both image features and gene expression signatures revealed that a large percentage of 
tumor stroma predicted poor prognosis. 
The high resolution of whole-slide tissue images poses a great computational challenge to 
researchers. For this reason, many previous studies only focused on selected views in tissue 
microarrays or a few representative image tiles in whole-slide images (2,5). Since tumor is a highly 
heterogeneous disease, image features extracted from a much larger area of the tumor would be 
more likely to ensure the robustness of the derived prognostic model. Our prognostic model was 
established on the fully automated quantitative image features that were extracted from whole-
slide histopathological images, which could avoid biases or discrepancies arising from only using 
a small portion of the tumor. 
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Our study is limited to only one large ccRCC patient cohort as it is difficult to find other cohorts 
that have matched histopathological images, gene expression profiles, and survival information. 
However, the performance of our prognostic model was strictly assessed by cross validation. The 
model selection was performed by 10-fold cross validation on the training set, and then the selected 
model was applied to the held-out test samples to predict risk indices. Another technical 
contribution of this work lies in the fact that we used only the cryohistological images from TCGA. 
Usually for each TCGA solid tumor sample, two histopathological images are generated – the 
H&E stained diagnostic image and the cryohistological image from a slice of tissue immediately 
adjacent to the tissue used for generating the omics data. Thus, due to spatial proximity, the 
cryohistological image is a more accurate reflection of the molecular profiles of the tissue for the 
omics data. However, due to processing artifact, many of these images appear damaged and cannot 
be processed for tissue features using previous methods, preventing accurate characterization on 
the tumor morphology. Here we showed that the cell nucleic features suggestive of stromal cells 
indeed correlated well with the gene expression profiles of extracellular matrix and stromal genes, 
suggesting in such images, albeit for the artifacts affecting texture analysis, the cell nucleic features 
can still be used.  
Finally, although our study focused on predicting survival for ccRCC patients, we believe that 
the workflow of integrative analysis of histopathological images with genomic data could be easily 
applied to other cancer types or to predict response of specific treatments, which would allow for 
better patient management and cancer care.  
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Tables  
Table 1. Demographic and clinical characteristics. 
Characteristics Summary 
Patient No. 410 
Age (years)  
   Range 26-90 
   Median 60 
Gender  
   Female 140 (34.2%) 
   Male 270 (65.8%) 
Follow-up (months)  
   Range 1.3-112.6 
   Median 37.8 
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Death 135 (32.9%) 
Grade  
   G1 7 (1.7%) 
   G2 171 (41.7%) 
   G3 169 (41.2%) 
   G4 63 (15.4%) 
Stage  
   Stage I 202 (49.3%) 
   Stage II 41 (10%) 
   Stage III 98 (23.9%) 
   Stage IV 69 (16.8%) 
 
 
Table 2. Survival-associated image features and eigengenes, identified by Kaplan-Meier estimator 
and log-rank test (p < 0.05). For each variable, patients were stratified into low and high groups 
using the median as cut-off point.  For P/N, P means positive relation to survival (i.e., patients with 
high feature values have good prognosis), whereas N means negative relation to survival.  
Feature P value P/N Feature P value  P/N 
rMean_bin10 2.23e-5 N gMean_entropy 0.0194 N 
rMean_bin6 8.55e-5 P ratio_std 0.0245 N 
rMean_std 1.18e-4 N rMean_kurtosis 0.0269 P 
rMean_entropy 2.45e-4 N ratio_bin8 0.0297 N 
gMean_std 7.70e-4 N ratio_bin9 0.0312 N 
rMean_bin5 0.0010 P area_std 0.0319 N 
major_bin9 0.0022 N ratio_bin5 0.0322 N 
major_entropy 0.0028 N ratio_mean 0.0324 N 
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area_bin5 0.0056 P major_bin1 0.0333 N 
major_bin4 0.0058 P major_bin2 0.0337 N 
ratio_bin6 0.0059 N bMean_bin10 0.0338 N 
major_bin8 0.0060 N major_bin10 0.0366 N 
major_std 0.0072 N bMean_std 0.0407 N 
area_bin7 0.0089 P eigengene3 7.46e-6 P 
rMean_bin9 0.0097 N eigengene9 1.19e-4 N 
major_bin5 0.0113 P eigengene13 9.39e-4 P 
gMean_bin10 0.0113 N eigengene11 0.0013 N 
area_bin6 0.0124 P eigengene1 0.0217 N 
bMean_entropy 0.0164 N eigengene2 0.0237 N 
ratio_bin7 0.0176 N    
 
Table 3. Univariate and multivariate Cox proportional hazards analysis of the prognostic values 
of lasso-Cox risk index and other prognostic factors. HR, hazard ratio. CI, confidence interval. 
 Univariate Cox regression Multivariate Cox regression 
Variable HR (95% CI) P value HR (95% CI) P value 
Lasso-Cox 3.06 (2.10-4.45) 5.02e-9 2.26 (1.46-3.49) 2.31e-4 
Clinical     
   Grade 2.38 (1.63-3.5) 8.45e-6 1.46 (0.95-2.23) 8.22e-2 
   Stage 3.68 (2.57-5.27) 1.12e-12 3.00 (2.00-4.49) 9.23e-8 
Gene expression     
   CSNK2A1 0.90 (0.64-1.26) 5.34e-1 1.07 (0.74-1.56) 7.11e-1 
   SPP1 1.15 (0.82-1.61) 4.14e-1 1.10 (0.75-1.63) 6.20e-1 
   DEFB1 1.41 (1.00-1.98) 4.99e-2 1.36 (0.95-1.95) 9.71e-2 
   PECAM1 0.77 (0.55-1.09) 1.40e-1 1.04 (0.69-1.58) 8.45e-1 
   EDNRB 0.50 (0.35-0.71) 9.10e-5 0.96 (0.59-1.57) 8.77e-1 
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   TSPAN7 0.54 (0.38-0.76) 5.12e-4 1.03 (0.64-1.67) 9.07e-1 
Somatic mutation     
   VHL 0.99 (0.70-1.38) 9.33e-1 1.23 (0.86-1.75) 2.57e-1 
   PBRM1 0.85 (0.58-1.24) 3.94e-1 1.03 (0.69-1.54) 8.85e-1 
   BAP1 1.49 (0.78-2.85) 2.22e-1 1.49 (0.74-3.00) 2.60e-1 
   SETD2 1.29 (0.77-2.14) 3.29e-1 1.03 (0.62-1.74) 9.00e-1 
   TP53 2.26 (1.00-5.15) 5.13e-2 2.86 (1.19-6.86) 1.85e-2 
 
 
 
 
 
Figure legends 
Figure 1. Data analysis and integration workflow. (A) Cellular morphological feature extraction 
pipeline. (B) Schematic diagram for gene co-expression analysis and summarization. (C) 
Integrative analysis of image features with eigengenes. Univariate survival analysis is used for an 
initial selection of survival-associated variables, and then these variables are used to train a lasso-
Cox prognostic model. Correlation between image features and eigengenes is also explored.  
 
Figure 2. Image features and eigengenes predict the survival outcomes of ccRCC patients. Both 
image features (A and B) and eigengenes (C) identify poor-prognosis subtypes with high 
percentage of stroma. Gene module 2 is enriched with extracellular matrix genes. RMean_bin10 
(D) and eigengene3 (E) are the most significant variables for image features and eigengenes, 
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respectively. Integrative analysis of histopathological images and genomic data using lasso-Cox 
can significantly improve the prognosis prediction power (F).  
 
Figure 3. Pairwise correlation heat map between 33 survival-associated image features and all 15 
eigengenes, using Spearman rank correlation.  
 
Figure 4. Image features and eigengenes predict the survival outcomes in early-stage (stage I and 
II) ccRCC patients. Stage is strongly associated with survival (A) but cannot stratify early-stage 
patients (B). However, image features (C, D), eigengenes (E), and lasso-Cox model (F) are 
significantly related to survival in early-stage patients. 
